Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides.
Wada F, Yamamoto T, Kobayashi T, Tachibana K, Ito KR, Hamasaki M, Kayaba Y, Terada C, Yamayoshi A, Obika S, Harada-Shiba M.
Wada F, et al. Among authors: ito kr.
Mol Ther Nucleic Acids. 2021 Oct 19;26:957-969. doi: 10.1016/j.omtn.2021.10.008. eCollection 2021 Dec 3.
Mol Ther Nucleic Acids. 2021.
PMID: 34760338
Free PMC article.